Using breast cancer as an example, recent research has revealed that the impact of autoimmune disorders on breast cancer development extends far beyond the initially recognized association with thyroid disease, particularly the involvement of both anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies (6, 7). This evidence concerns the gene TPO and breast cancer.